TRIM33 has also been found to be dysfunctional in many blood cancers and is mainly considered to have tumor suppressor activity [16], with the exception of B-cell acute lymphoblastic leukemia (B-ALL), where it is identified as an oncogene [22]. This evidence concerns the gene TRIM33 and neoplasm.